WuXi Biologics receives double honors at 2026 HERA for ESG reporting and environmental excellence
WuXi Biologics (2269.HK) won Best ESG Report (Large-Cap) and Excellence in Environmental Positive Impact at the ninth Hong Kong ESG Reporting Awards, becoming the only pharmaceutical company to receive a Grand Award. The company said the awards recognize its ongoing commitment to transparent ESG disclosure and measurable environmental progress across its global operations.
Primary source
Company press release (PR Newswire), November 3, 2026
WuXi Biologics Receives Double Honors at 2026 HERA for ESG Reporting and Environmental Excellence
Read the source: WuXi Biologics Receives Double Honors at 2026 HERA for ESG Reporting and Environmental Excellence prnewswire.com
Machine-summarized from the source above; not independently reported. How we use automation